Loading the section
The price of Corcept Therapeutics Incorporated (CORT) on October 9, 2026 is 122.21 USD, +3.10% on the day. Over 52 weeks the stock traded between 28.66 USD and 126.38 USD; the price now sits 92% of the way up that range. Over the past year the price changed by +31.24%. The P/E ratio is 265.3, which is above the sector median (24.8). Market capitalization is 12.56 billion USD, rank 21 among 374 stocks of the same industry with a known capitalization.
Prices delayed by 15 minutes
Next earnings report: 03 November 2026 · Earnings calendar
Corcept Therapeutics Incorporated trades on Nasdaq under the ticker CORT. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks CORT has traded between 28.66 $ and 126.38 $. As of 09 October 2026 the price stood 91.98 % of the way from the 52-week low to the high.
Over one year CORT shares rose 31.24 %; over six months they rose 180.57 %. Volatility over 90 days is 56.98 %. Dividends are not included: this is price change only, as of 09 October 2026.
CORT trades at a price-to-earnings ratio of 265, above the sector median of 24.8. Price to sales is 16.3, above the sector median of 3.9. Price to book is 19.7, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 118.56 | 119.16 | 115.80 | 118.54 | 496,600 |
| 07 October 2026 | 119.00 | 122.00 | 117.23 | 119.60 | 634,900 |
| 06 October 2026 | 122.20 | 122.54 | 115.11 | 119.57 | 790,000 |
| 05 October 2026 | 115.59 | 122.81 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Corcept treats a rare hormonal disorder and is trying to apply the same mechanism in oncology.
The lead drug blocks the action of cortisol in a syndrome where the body produces it in excess. The condition is rare, diagnosed late, and treatments were few — the company took that niche and remains profitable, which is unusual for a small pharmaceutical company.
What follows depends on two things: a next-generation drug without the first one's side effects, and applying the same mechanism in ovarian cancer, where early data are encouraging. A constant background is litigation with generic manufacturers, since the active substance has long been known. Risks: patent protection, trial outcomes and the narrowness of the current market. The company pays no dividend.
Address:101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065, US
Corcept Therapeutics Incorporated reported revenue of 769M $ and net income of 47M $ over the last four quarters. Net margin is 6.16 %. Revenue changed by +12.20 % year over year. Earnings per share are 0.35 $. Market capitalisation is 12.6B $.
CORT has a return on equity of 7.42 %, above the sector median of −41.68 %. Return on assets is 5.81 %, above the sector median of −32.11 %. Operating margin is −1.07 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 115.50 |
| 122.03 |
| 1M |
| 02 October 2026 | 114.38 | 117.32 | 113.90 | 116.23 | 960,200 |
| 01 October 2026 | 114.29 | 115.98 | 111.94 | 114.03 | 879,000 |
| 30 September 2026 | 114.80 | 118.07 | 113.98 | 115.23 | 910,300 |
| 29 September 2026 | 115.92 | 120.51 | 113.16 | 114.74 | 964,400 |
| 28 September 2026 | 116.00 | 117.07 | 114.36 | 115.63 | 1M |
| 25 September 2026 | 119.00 | 120.44 | 114.51 | 116.10 | 800,800 |
| 24 September 2026 | 111.86 | 119.15 | 111.68 | 118.51 | 983,600 |
| 23 September 2026 | 117.33 | 118.79 | 112.05 | 112.94 | 809,800 |
| 22 September 2026 | 113.96 | 119.00 | 113.09 | 117.51 | 810,200 |
| 21 September 2026 | 110.29 | 116.65 | 109.00 | 113.76 | 1M |
| 18 September 2026 | 116.80 | 117.90 | 108.41 | 110.29 | 17M |
| 17 September 2026 | 113.18 | 115.09 | 111.07 | 114.86 | 883,600 |
| 16 September 2026 | 110.82 | 113.60 | 110.49 | 111.81 | 668,600 |
| 15 September 2026 | 111.97 | 112.80 | 109.40 | 110.82 | 1M |
| 14 September 2026 | 113.38 | 114.52 | 111.10 | 111.80 | 1M |
| 11 September 2026 | 115.22 | 117.84 | 109.30 | 112.79 | 1M |